← Back to Search

Breathing Exercises + Meditation for Glaucoma

N/A

Waitlist Available

Research Sponsored by Lawson Health Research Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Having no significant self-reported or physician-diagnosed mental health disorder

Patients diagnosed with glaucoma

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline visit, week 1, week 3, week 6, week 12

Awards & highlights

Study Summary

This trial aims to assess the feasibility of using breathing exercises and meditation to improve quality of life for people with glaucoma, the leading cause of irreversible blindness.

Who is the study for?

This trial is for glaucoma patients aged 40-65 who can consent, read English, sit comfortably for over half an hour, and have good hearing. They should be in stable physical health without serious mental disorders or recent substance abuse. Those with severe depression or unstable medical conditions are excluded.Check my eligibility

What is being tested?

The study tests if breathing exercises followed by meditation can improve life quality in glaucoma patients. Participants will either do these exercises or receive usual care and then answer online questionnaires about their well-being after 12 weeks.See study design

What are the potential side effects?

Since the intervention involves non-invasive practices like breathing exercises and meditation, significant side effects are not anticipated. However, some individuals might experience discomfort sitting still or mild stress during meditation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I do not have a significant mental health disorder.

Select...

I have been diagnosed with glaucoma.

Select...

I am between 40 and 65 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline visit, week 1, week 3, week 6, week 12

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline visit, week 1, week 3, week 6, week 12

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline visit, week 1, week 3, week 6, week 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Anxiety

Change in Depression

Change in Sleep quality

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Breathing Exercises followed by MeditationExperimental Treatment1 Intervention

Breathing exercises and Meditation taught by Prasanna Wellness, a non-profit organization, helps dissolve stress and create a proper system in the mind. These breathing exercises include slow deep breaths and rapid breaths and are followed by meditation. Participants will receive three weekly online instructions (90 minutes each) by trained instructors in addition to standard care. Weekly 60 minutes follow-ups will include 10 minutes of breathing exercises followed by 33 minutes of guided meditation practice, and then focus on participants' experiences with breathing exercise followed by meditation during the week, additional observations, and a review of relevant knowledge to support their home practice.

Group II: No InterventionActive Control1 Intervention

The usual standard of care for patients with glaucoma includes starting them on first line of drugs. Participants will be initiated and maintained on appropriate dosages of such medications as part of standard of care. The usual standard of care also includes an ophthalmic examination measuring best-corrected Snellen VA and pinhole acuities and a follow-up visit once a year.

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Lawson Health Research InstituteLead Sponsor

656 Previous Clinical Trials

413,378 Total Patients Enrolled

5 Trials studying Glaucoma

457 Patients Enrolled for Glaucoma

Media Library

Breathing Exercises followed by Meditation Clinical Trial Eligibility Overview. Trial Name: NCT05960513 — N/A

Glaucoma Research Study Groups: Breathing Exercises followed by Meditation, No Intervention

Glaucoma Clinical Trial 2023: Breathing Exercises followed by Meditation Highlights & Side Effects. Trial Name: NCT05960513 — N/A

Breathing Exercises followed by Meditation 2023 Treatment Timeline for Medical Study. Trial Name: NCT05960513 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the participant eligibility for this research restricted to individuals aged 18 or older?

"This particular trial is designed for patients aged 40 to 65. However, there are a total of 1820 trials that cater specifically to individuals younger and older than this range."

Answered by AI

Are there any opportunities for participants to join this trial?

"The details on clinicaltrials.gov show that this medical research is not presently seeking participants. This project was first advertised in September 1st of 2023 and its last update occured on July 21th, 2023. Despite the current lack of recruitment for this trial, there are 1952 other studies actively enlisting patients at this time."

Answered by AI

Is it feasible for me to be enrolled in this experiment?

"This clinical trial will accept patients between the ages of 40 and 65 who have been diagnosed with glaucoma. 50 participants are needed for this medical experiment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Impact of Breathing Exercises and Meditation on Improving Quality of Life in Glaucoma Patients

Monali Malvankar 2023. "Impact of Breathing Exercises and Meditation on Improving Quality of Life in Glaucoma Patients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05960513.

All > Glaucoma